-
1
-
-
84866732231
-
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
-
Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
-
(2012)
Eur Heart J
, vol.33
, pp. 2569-2619
-
-
Steg, P.G.1
James, S.K.2
Atar, D.3
-
2
-
-
84856158305
-
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
-
Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
-
(2011)
Eur Heart J
, vol.32
, pp. 2999-3054
-
-
Hamm, C.W.1
Bassand, J.P.2
Agewall, S.3
-
3
-
-
84891060793
-
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
-
Aradi D, Storey RF, Komocsi A, et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J 2014; 35: 209-215.
-
(2014)
Eur Heart J
, vol.35
, pp. 209-215
-
-
Aradi, D.1
Storey, R.F.2
Komocsi, A.3
-
4
-
-
84872228959
-
Impact of clopidogrel and potent P2Y 12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A systematic review and meta-analysis
-
Aradi D, Komócsi A, Vorobcsuk A, et al. Impact of clopidogrel and potent P2Y 12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Thrombosis and haemostasis 2013; 109: 93-101.
-
(2013)
Thrombosis and haemostasis
, vol.109
, pp. 93-101
-
-
Aradi, D.1
Komócsi, A.2
Vorobcsuk, A.3
-
5
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
-
6
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
-
7
-
-
0035908781
-
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
-
Mehta S, Yusuf S, Peters R, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533.
-
(2001)
Lancet
, vol.358
, pp. 527-533
-
-
Mehta, S.1
Yusuf, S.2
Peters, R.3
-
8
-
-
84890136652
-
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patientlevel data
-
Steg PG, Bhatt DL, Hamm CW, et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patientlevel data. Lancet 2013; 382: 1981-1992.
-
(2013)
Lancet
, vol.382
, pp. 1981-1992
-
-
Steg, P.G.1
Bhatt, D.L.2
Hamm, C.W.3
-
9
-
-
84890025521
-
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischaemia and bleeding
-
Tantry US, Bonello L, Aradi D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischaemia and bleeding. J Am Coll Cardiol 2013; 62: 2261-2273.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 2261-2273
-
-
Tantry, U.S.1
Bonello, L.2
Aradi, D.3
-
10
-
-
84886260869
-
2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
-
Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003.
-
(2013)
Eur Heart J
, vol.34
, pp. 2949-3003
-
-
Montalescot, G.1
Sechtem, U.2
Achenbach, S.3
-
11
-
-
37249068049
-
Platelet activation and atherothrombosis
-
Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482-2494.
-
(2007)
N Engl J Med
, vol.357
, pp. 2482-2494
-
-
Davi, G.1
Patrono, C.2
-
12
-
-
34347340649
-
Evaluation of dose-related effects of aspirin on platelet function: Results from the Aspirin-Induced Platelet Effect (ASPECT) study
-
Gurbel PA, Bliden KP, DiChiara J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007; 115: 3156-3164.
-
(2007)
Circulation
, vol.115
, pp. 3156-3164
-
-
Gurbel, P.A.1
Bliden, K.P.2
DiChiara, J.3
-
13
-
-
84875730184
-
New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals
-
Kovacs EG, Katona E, Bereczky Z, et al. New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. Thromb Res 2013; 131: 320-324.
-
(2013)
Thromb Res
, vol.131
, pp. 320-324
-
-
Kovacs, E.G.1
Katona, E.2
Bereczky, Z.3
-
14
-
-
84898803325
-
Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods
-
Kovacs EG, Katona E, Bereczky Z, et al. Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods. Thromb Res 2014; 133: 811-816.
-
(2014)
Thromb Res
, vol.133
, pp. 811-816
-
-
Kovacs, E.G.1
Katona, E.2
Bereczky, Z.3
-
15
-
-
84882248344
-
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): A prospective multicentre registry study
-
Stone GW, Witzenbichler B, Weisz G, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet 2013; 382: 614-623.
-
(2013)
Lancet
, vol.382
, pp. 614-623
-
-
Stone, G.W.1
Witzenbichler, B.2
Weisz, G.3
-
16
-
-
77956290748
-
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
-
Mehta SR, Bassand JP, Chrolavicius S, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010; 363: 930-942.
-
(2010)
N Engl J Med
, vol.363
, pp. 930-942
-
-
Mehta, S.R.1
Bassand, J.P.2
Chrolavicius, S.3
-
17
-
-
84874759680
-
Hirudin anticoagulation allows more rapid determination of P2Y(1)(2) inhibition by the VerifyNow P2Y12 assay
-
Sumaya W, Daly RL, Mehra S, et al. Hirudin anticoagulation allows more rapid determination of P2Y(1)(2) inhibition by the VerifyNow P2Y12 assay. Thromb Haemost 2013; 109: 550-555.
-
(2013)
Thromb Haemost
, vol.109
, pp. 550-555
-
-
Sumaya, W.1
Daly, R.L.2
Mehra, S.3
-
19
-
-
77950221899
-
The effect of a pneumatic tube transport system on platelet aggregation using optical aggregometry and the PFA-100
-
Hubner U, Bockel-Frohnhofer N, Hummel B, et al. The effect of a pneumatic tube transport system on platelet aggregation using optical aggregometry and the PFA-100. Clin Lab 2010; 56: 59-64.
-
(2010)
Clin Lab
, vol.56
, pp. 59-64
-
-
Hubner, U.1
Bockel-Frohnhofer, N.2
Hummel, B.3
-
20
-
-
84876130984
-
Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate(R) analyser
-
Johnston LR, Larsen PD, La Flamme AC, et al. Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate(R) analyser. Platelets 2013; 24: 303-307.
-
(2013)
Platelets
, vol.24
, pp. 303-307
-
-
Johnston, L.R.1
Larsen, P.D.2
La Flamme, A.C.3
-
21
-
-
84857563727
-
High on-treatment platelet reactivity assessed by various platelet function tests: Is the consensus-defined cut-off of VASP-P platelet reactivity index too low?
-
Jeong YH, Bliden KP, Tantry US, et al. High on-treatment platelet reactivity assessed by various platelet function tests: is the consensus-defined cut-off of VASP-P platelet reactivity index too low? J Thromb Haemost 2012; 10: 487-489.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 487-489
-
-
Jeong, Y.H.1
Bliden, K.P.2
Tantry, U.S.3
-
22
-
-
57349185925
-
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients
-
Lordkipanidzé M, Pharand C, Nguyen T, et al. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 2008; 29: 2877-2885.
-
(2008)
Eur Heart J
, vol.29
, pp. 2877-2885
-
-
Lordkipanidzé, M.1
Pharand, C.2
Nguyen, T.3
-
23
-
-
77249113768
-
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation
-
Breet NJ, van Werkum JW, Bouman HJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. J Am Med Assoc 2010; 303: 754-762.
-
(2010)
J Am Med Assoc
, vol.303
, pp. 754-762
-
-
Breet, N.J.1
van Werkum, J.W.2
Bouman, H.J.3
-
24
-
-
84859181019
-
Phenotyping vs genotyping for prediction of clopidogrel efficacy and safety: The PEGASUS-PCI study
-
Siller-Matula JM, Delle-Karth G, Lang IM, et al. Phenotyping vs genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. J Thromb Haemost 2012; 10: 529-542.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 529-542
-
-
Siller-Matula, J.M.1
Delle-Karth, G.2
Lang, I.M.3
-
25
-
-
79961046361
-
Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events
-
Freynhofer MK, Brozovic I, Bruno V, et al. Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events. Thromb Haemost 2011; 106: 230-239.
-
(2011)
Thromb Haemost
, vol.106
, pp. 230-239
-
-
Freynhofer, M.K.1
Brozovic, I.2
Bruno, V.3
-
26
-
-
70349510067
-
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients
-
Cuisset T, Frere C, Quilici J, et al. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. Am J Cardiol 2009; 104: 1078-1082.
-
(2009)
Am J Cardiol
, vol.104
, pp. 1078-1082
-
-
Cuisset, T.1
Frere, C.2
Quilici, J.3
-
27
-
-
69349100568
-
Sensitive troponin I assay in early diagnosis of acute myocardial infarction
-
Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868-877.
-
(2009)
N Engl J Med
, vol.361
, pp. 868-877
-
-
Keller, T.1
Zeller, T.2
Peetz, D.3
-
28
-
-
84878337221
-
Biomarkers in atrial fibrillation: A clinical review
-
Hijazi Z, Oldgren J, Siegbahn A, et al. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 2013; 34: 1475-1480.
-
(2013)
Eur Heart J
, vol.34
, pp. 1475-1480
-
-
Hijazi, Z.1
Oldgren, J.2
Siegbahn, A.3
-
29
-
-
84877060794
-
Evaluating the clinical usefulness of platelet function testing: Considerations for the proper application and interpretation of performance measures
-
Dahlen JR, Price MJ, Parise H, et al. Evaluating the clinical usefulness of platelet function testing: Considerations for the proper application and interpretation of performance measures. Thromb Haemost 2013; 109: 808-816.
-
(2013)
Thromb Haemost
, vol.109
, pp. 808-816
-
-
Dahlen, J.R.1
Price, M.J.2
Parise, H.3
-
30
-
-
34547860049
-
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
-
Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 2007; 116: 745-754.
-
(2007)
Circulation
, vol.116
, pp. 745-754
-
-
Airoldi, F.1
Colombo, A.2
Morici, N.3
-
31
-
-
84867529539
-
Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction
-
Brodie B, Pokharel Y, Garg A, et al. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2012; 5: 1043-1051.
-
(2012)
JACC Cardiovasc Interv
, vol.5
, pp. 1043-1051
-
-
Brodie, B.1
Pokharel, Y.2
Garg, A.3
-
32
-
-
80054919425
-
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis
-
Cayla G, Hulot JS, O'Connor SA, et al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. J Am Med Assoc 2011; 306: 1765-1774.
-
(2011)
J Am Med Assoc
, vol.306
, pp. 1765-1774
-
-
Cayla, G.1
Hulot, J.S.2
O'Connor, S.A.3
-
33
-
-
77956353401
-
Prognostic significance of high onclopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
-
Aradi D, Komocsi A, Vorobcsuk A, et al. Prognostic significance of high onclopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J 2010; 160: 543-551.
-
(2010)
Am Heart J
, vol.160
, pp. 543-551
-
-
Aradi, D.1
Komocsi, A.2
Vorobcsuk, A.3
-
34
-
-
80052167250
-
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
-
Brar SS, ten Berg J, Marcucci R, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol 2011; 58: 1945-1954.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1945-1954
-
-
Brar, S.S.1
ten Berg, J.2
Marcucci, R.3
-
35
-
-
77953753809
-
Clinical implications of clopidogrel non-response in cardiovascular patients: A systematic review and meta-analysis
-
Combescure C, Fontana P, Mallouk N, et al. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2010; 8: 923-933.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 923-933
-
-
Combescure, C.1
Fontana, P.2
Mallouk, N.3
-
36
-
-
77952075376
-
Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis
-
Sofi F, Marcucci R, Gori AM, et al. Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb Haemost 2010; 103: 841-848.
-
(2010)
Thromb Haemost
, vol.103
, pp. 841-848
-
-
Sofi, F.1
Marcucci, R.2
Gori, A.M.3
-
37
-
-
84893031423
-
Impact of Point-of-Care Platelet Function Testing among Patients with and without Acute Coronary Syndromes Undergoing Pci with Drug-Eluting Stents: An Adapt-Des Substudy
-
Kirtane AJ, Rinaldi M, Parise H, et al. Impact of Point-of-Care Platelet Function Testing among Patients with and without Acute Coronary Syndromes Undergoing Pci with Drug-Eluting Stents: An Adapt-Des Substudy. J Am Coll Cardiol 2012; 59: E291.
-
(2012)
J Am Coll Cardiol
, vol.59
-
-
Kirtane, A.J.1
Rinaldi, M.2
Parise, H.3
-
38
-
-
84868332790
-
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularisation: The TRILOGY ACS platelet function substudy
-
Gurbel P, Erlinge D, Ohman E, et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularisation: the TRILOGY ACS platelet function substudy. J Am Med Assoc 2012; 308: 1785-1794.
-
(2012)
J Am Med Assoc
, vol.308
, pp. 1785-1794
-
-
Gurbel, P.1
Erlinge, D.2
Ohman, E.3
-
39
-
-
77950508416
-
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND study
-
Gurbel P, Bliden K, Butler K, et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation 2010; 121: 1188-1199.
-
(2010)
Circulation
, vol.121
, pp. 1188-1199
-
-
Gurbel, P.1
Bliden, K.2
Butler, K.3
-
40
-
-
37349111065
-
Prasugrel compared with high loadingand maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial
-
Wiviott S, Trenk D, Frelinger A, et al. Prasugrel compared with high loadingand maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007; 116: 2923-2932.
-
(2007)
Circulation
, vol.116
, pp. 2923-2932
-
-
Wiviott, S.1
Trenk, D.2
Frelinger, A.3
-
41
-
-
79960603731
-
High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes
-
Bonello L, Pansieri M, Mancini J, et al. High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes. J Am Coll Cardiol 2011; 58: 467-473.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 467-473
-
-
Bonello, L.1
Pansieri, M.2
Mancini, J.3
-
42
-
-
44949173754
-
Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
-
Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008; 29: 992-1000.
-
(2008)
Eur Heart J
, vol.29
, pp. 992-1000
-
-
Price, M.J.1
Endemann, S.2
Gollapudi, R.R.3
-
43
-
-
80052573217
-
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial
-
Price M, Angiolillo D, Teirstein P, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation 2011; 124: 1132-1137.
-
(2011)
Circulation
, vol.124
, pp. 1132-1137
-
-
Price, M.1
Angiolillo, D.2
Teirstein, P.3
-
44
-
-
77955465123
-
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents
-
Schulz S, Sibbing D, Braun S, et al. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. Am Heart J 2010; 160: 355-361.
-
(2010)
Am Heart J
, vol.160
, pp. 355-361
-
-
Schulz, S.1
Sibbing, D.2
Braun, S.3
-
45
-
-
84899713032
-
Optimizing P2Y-receptor inhibition in acute coronary syndrome patients based on platelet function testing: Impact of prasugrel and high-dose clopidogrel
-
Epub ahead of print
-
Aradi D, Tornyos A, Pinter T, et al. Optimizing P2Y-receptor inhibition in acute coronary syndrome patients based on platelet function testing: impact of prasugrel and high-dose clopidogrel. J Am Coll Cardiol 2014; Epub ahead of print.
-
(2014)
J Am Coll Cardiol
-
-
Aradi, D.1
Tornyos, A.2
Pinter, T.3
-
46
-
-
36949000480
-
The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis
-
Blindt R, Stellbrink K, de Taeye A, et al. The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. Thromb Haemost 2007; 98: 1329-1334.
-
(2007)
Thromb Haemost
, vol.98
, pp. 1329-1334
-
-
Blindt, R.1
Stellbrink, K.2
de Taeye, A.3
-
47
-
-
34447636769
-
Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events
-
Bonello L, Paganelli F, Arpin-Bornet M, et al. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 2007; 5: 1630-1636.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1630-1636
-
-
Bonello, L.1
Paganelli, F.2
Arpin-Bornet, M.3
-
48
-
-
78049417758
-
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: A prospective registry
-
El Ghannudi S, Ohlmann P, Meyer N, et al. Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry. JACC Cardiovasc Interv 2010; 3: 648-656.
-
(2010)
JACC Cardiovasc Interv
, vol.3
, pp. 648-656
-
-
El Ghannudi, S.1
Ohlmann, P.2
Meyer, N.3
-
49
-
-
80051533777
-
Bleeding in acute coronary syndromes and percutaneous coronary interventions: Position paper by the Working Group on Thrombosis of the European Society of Cardiology
-
Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011; 32: 1854-1864.
-
(2011)
Eur Heart J
, vol.32
, pp. 1854-1864
-
-
Steg, P.G.1
Huber, K.2
Andreotti, F.3
-
50
-
-
74749097435
-
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement
-
Sibbing D, Schulz S, Braun S, et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 2010; 8: 250-256.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 250-256
-
-
Sibbing, D.1
Schulz, S.2
Braun, S.3
-
51
-
-
79958110089
-
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome
-
Campo G, Parrinello G, Ferraresi P, et al. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol 2011; 57: 2474-2483.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 2474-2483
-
-
Campo, G.1
Parrinello, G.2
Ferraresi, P.3
-
52
-
-
84882771753
-
Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients Treated With Thienopyridine
-
Cuisset T, Grosdidier C, Loundou AD, et al. Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients Treated With Thienopyridine. JACC: Cardiovasc Interv 2013; 6: 854-863.
-
(2013)
JACC: Cardiovasc Interv
, vol.6
, pp. 854-863
-
-
Cuisset, T.1
Grosdidier, C.2
Loundou, A.D.3
-
53
-
-
84866861394
-
Relationship between post-treatment platelet reactivity and ischaemic and bleeding events at 1-year follow-up in patients receiving prasugrel
-
Bonello L, Mancini J, Pansieri M, et al. Relationship between post-treatment platelet reactivity and ischaemic and bleeding events at 1-year follow-up in patients receiving prasugrel. J Thromb Haemost 2012; 10: 1999-2005.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1999-2005
-
-
Bonello, L.1
Mancini, J.2
Pansieri, M.3
-
54
-
-
84858767790
-
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study
-
Mangiacapra F, Patti G, Barbato E, et al. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study. JACC Cardiovasc Interv 2012; 5: 281-289.
-
(2012)
JACC Cardiovasc Interv
, vol.5
, pp. 281-289
-
-
Mangiacapra, F.1
Patti, G.2
Barbato, E.3
-
55
-
-
82955189275
-
A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation
-
Park DW, Lee SW, Yun SC, et al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol 2011; 58: 2630-2639.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 2630-2639
-
-
Park, D.W.1
Lee, S.W.2
Yun, S.C.3
-
56
-
-
84873530056
-
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction
-
Alexopoulos D, Xanthopoulou I, Gkizas V, et al. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. JACC Cardiovasc Interv 2012; 5: 797-804.
-
(2012)
JACC Cardiovasc Interv
, vol.5
, pp. 797-804
-
-
Alexopoulos, D.1
Xanthopoulou, I.2
Gkizas, V.3
-
57
-
-
84925350864
-
Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study
-
Kirtane AJ; Stuckey T; Xu K et al. Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study. J Am Coll Cardiol 2013; 62: B48-49.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. B48-B49
-
-
Kirtane, A.J.1
Stuckey, T.2
Xu, K.3
-
58
-
-
84881283025
-
Switching acute coronary syndrome patients from prasugrel to clopidogrel
-
Kerneis M, Silvain J, Abtan J, et al. Switching acute coronary syndrome patients from prasugrel to clopidogrel. JACC Cardiovasc Interv 2013; 6: 158-165.
-
(2013)
JACC Cardiovasc Interv
, vol.6
, pp. 158-165
-
-
Kerneis, M.1
Silvain, J.2
Abtan, J.3
-
59
-
-
79952598836
-
Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
-
Price MJ, Berger PB, Teirstein PS, et al. Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. J Am Med Assoc 2011; 305: 1097-1105.
-
(2011)
J Am Med Assoc
, vol.305
, pp. 1097-1105
-
-
Price, M.J.1
Berger, P.B.2
Teirstein, P.S.3
-
60
-
-
84870032410
-
Bedside monitoring to adjust antiplatelet therapy for coronary stenting
-
Collet JP, Cuisset T, Range G, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012; 367: 2100-2109.
-
(2012)
N Engl J Med
, vol.367
, pp. 2100-2109
-
-
Collet, J.P.1
Cuisset, T.2
Range, G.3
-
61
-
-
84883281361
-
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
-
Aradi D, Komocsi A, Price MJ, et al. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol 2013; 167: 2140-2148.
-
(2013)
Int J Cardiol
, vol.167
, pp. 2140-2148
-
-
Aradi, D.1
Komocsi, A.2
Price, M.J.3
-
62
-
-
84861857758
-
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study
-
Trenk D, Stone GW, Gawaz M, et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J Am Coll Cardiol 2012; 59: 2159-2164.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 2159-2164
-
-
Trenk, D.1
Stone, G.W.2
Gawaz, M.3
-
63
-
-
84883263516
-
Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study
-
Siller-Matula JM, Francesconi M, Dechant C, et al. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. Int J Cardiol 2013; 167: 2018-2023.
-
(2013)
Int J Cardiol
, vol.167
, pp. 2018-2023
-
-
Siller-Matula, J.M.1
Francesconi, M.2
Dechant, C.3
-
64
-
-
84905190256
-
A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry
-
Mayer K, Schulz S, Bernlochner I, et al. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Thromb Haemost 2014; 112: 342-351.
-
(2014)
Thromb Haemost
, vol.112
, pp. 342-351
-
-
Mayer, K.1
Schulz, S.2
Bernlochner, I.3
-
65
-
-
84860789698
-
Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study
-
Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. JACC Cardiovasc Interv 2012; 5: 261-269.
-
(2012)
JACC Cardiovasc Interv
, vol.5
, pp. 261-269
-
-
Mahla, E.1
Suarez, T.A.2
Bliden, K.P.3
-
66
-
-
84867793423
-
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
-
Ferraris VA, Saha SP, Oestreich JH, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thoracic Surg 2012; 94: 1761-1781.
-
(2012)
Ann Thoracic Surg
, vol.94
, pp. 1761-1781
-
-
Ferraris, V.A.1
Saha, S.P.2
Oestreich, J.H.3
-
67
-
-
84902595318
-
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
-
Sousa-Uva M, Storey R, Huber K, et al. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Eur Heart J 2014; 35: 1510-1514.
-
(2014)
Eur Heart J
, vol.35
, pp. 1510-1514
-
-
Sousa-Uva, M.1
Storey, R.2
Huber, K.3
-
68
-
-
84893175187
-
A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients
-
Straub N, Beivers A, Lenk E, et al. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients. Thromb Haemost 2014; 111: 290-299.
-
(2014)
Thromb Haemost
, vol.111
, pp. 290-299
-
-
Straub, N.1
Beivers, A.2
Lenk, E.3
-
69
-
-
80053080512
-
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI
-
Parodi G, Marcucci R, Valenti R, et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. J Am Med Assoc 2011; 306: 1215-1223.
-
(2011)
J Am Med Assoc
, vol.306
, pp. 1215-1223
-
-
Parodi, G.1
Marcucci, R.2
Valenti, R.3
-
70
-
-
60949083948
-
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis
-
Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53: 849-856.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 849-856
-
-
Sibbing, D.1
Braun, S.2
Morath, T.3
-
71
-
-
35048856897
-
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
-
Frere C, Cuisset T, Quilici J, et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 2007; 98: 838-843.
-
(2007)
Thromb Haemost
, vol.98
, pp. 838-843
-
-
Frere, C.1
Cuisset, T.2
Quilici, J.3
|